A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109

2005 ◽  
Vol 56 (1) ◽  
pp. 39-45 ◽  
Author(s):  
Peter J. Van Veldhuizen ◽  
James R. Faulkner ◽  
Primo N. Lara ◽  
Paul H. Gumerlock ◽  
J. Wendall. Goodwin ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Advanced Renal Cell Carcinoma ◽  
Oncology Group ◽  
Southwest Oncology Group ◽  
Group Trial

scholarly journals Predictors of Survival of Advanced Renal Cell Carcinoma: Long-Term Results From Southwest Oncology Group Trial S8949

2009 ◽  
Vol 181 (2) ◽  
pp. 512-517 ◽  
Author(s):  
Primo N. Lara ◽  
Catherine M. Tangen ◽  
Sarah J. Conlon ◽  
Robert C. Flanigan ◽  
E. David Crawford
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Long Term Results ◽  
Advanced Renal Cell Carcinoma ◽  
Oncology Group ◽  
Southwest Oncology Group ◽  
Group Trial

Subcutaneous Recombinant Interleukin-2 and a-Interferon in Patients with Advanced Renal Cell Carcinoma: Results of a Multicenter Phase II Study

1993 ◽  
Vol 8 (4) ◽  
pp. 289-300 ◽  
Author(s):  
Jens Atzpodien ◽  
Hartmut Kirchner ◽  
Peter de Mulder ◽  
Heiner Bodenstein ◽  
Tim Olivera ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Interleukin 2 ◽  
Advanced Renal Cell Carcinoma ◽  
Multicenter Phase ◽  
Recombinant Interleukin 2

12 Phase II study of lutetium-177-labeled anti carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma

2015 ◽  
Vol 14 (2) ◽  
pp. e12 ◽  
Author(s):  
C.H.J. Muselaers ◽  
T.J. Van Oostenbrugge ◽  
M.J. Boers-Sonderen ◽  
O.C. Boerman ◽  
I.M.E. Desar ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Monoclonal Antibody ◽  
Carbonic Anhydrase ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Carbonic Anhydrase Ix ◽  
Advanced Renal Cell Carcinoma

Phase II study of interferon gamma (rIFN-G) and vinblastine(VBL) in patients with advanced renal cell carcinoma (RCC)

1997 ◽  
Vol 33 ◽  
pp. S42
Author(s):  
C. Bacoyiannis ◽  
M.A. Dimopoulos ◽  
C. Nicolaides ◽  
G. Aravantinos ◽  
N. Xiros ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Interferon Gamma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Advanced Renal Cell Carcinoma

Rationale and Protocol of SOAP: A Phase II Study to Evaluate the Efficacy of Sorafenib as Second-Line Treatment after Pazopanib in Patients with Advanced Renal Cell Carcinoma

2014 ◽  
Vol 100 (6) ◽  
pp. e282-e285
Author(s):  
Roberto Iacovelli ◽  
Elena Verzoni ◽  
Paolo Grassi ◽  
Alessio Farcomeni ◽  
Filippo de Braud ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Advanced Renal Cell Carcinoma ◽  
Line Treatment ◽  
Second Line

Phase II study of bevacizumab and everolimus (RAD001) in the treatment of advanced renal cell carcinoma (RCC)

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 5010-5010 ◽  
Author(s):  
R. C. Whorf ◽  
J. D. Hainsworth ◽  
D. R. Spigel ◽  
D. A. Yardley ◽  
H. A. Burris ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Advanced Renal Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document